FDA - Food and Drug Administration
Trump claims unnamed drug can bring people back from death, boasts success of Right To Try Act
"We've taken people that were dead. We had a person given the last rites - gone, the kids are crying, and everything - and started them on this drug. And the person became better," Trump insisted.
FDA launches safety study of abortion pill Mifepristone with White House approval
Trump to expand prescription drug site with 600 cheaper generic medicines in push to lower costs
Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
RFK Jr.’s health department ordered withdrawal of studies showing vaccine efficiency - report
During the 2024 presidential election campaign, President Donald Trump promised to give anti-vaccine activist Robert F. Kennedy, Jr. a prominent role in the White House’s health care section.
'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval
Most patients began to hear within weeks, with 80% achieving at least significant hearing restoration and 42% reaching normal hearing, including the ability to hear whispers.
Trump signs order to accelerate Ibogaine research for veterans with PTSD
The order focuses on advancing studies of ibogaine, a Schedule I psychedelic drug, for use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideatiation, and opiod addiction.
Israeli pride: Phytolon receives FDA approval – sparks significant interest in the U.S.
Millennium FoodTech R&D Partnership: Portfolio company Phytollon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S.
FDA clears AI model to triage urgent CT findings, Israeli firm says
Aidoc won FDA clearance for a 'foundation model' clinical AI that triages 14 abdomen-CT indications in one workflow, aiming to surface urgent findings faster amid ED crowding and imaging backlogs.
FDA clears first US trial of Israel’s EndoArt synthetic corneal implant
EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment targeted to begin in March 2026.
Arizona couple admits in court to faking cancer-curing 'smart chip' device
At clinics in Arizona and several other states, Mary Blakley and her husband told patients that, for just $300, they could provide a full-body scan to detect a variety of potential illnesses.
Forget the injections: The FDA has approved a daily weight-loss pill for the first time
A daily pill version of the weight-loss drug Wegovy shows significant weight reduction, greater convenience, and hope for making treatment accessible to millions of patients.
Weight-loss pill approval set to accelerate food industry product overhauls
As GLP-1 pills become widely available, food companies and restaurants are adjusting to rising demand for high-protein, smaller portions to meet weight-loss trends.
Kennedy seeks to cut US children's access to gender-affirming care
Kennedy proposed rules barring hospitals that provide such care from participating in Medicare and Medicaid programs and prohibiting Medicaid from paying for it.
